Ectopic lipid deposition in muscle and liver is associated with the pathogenesis of type II diabetes. Hagberg et al. (2012) report that targeting the vascular endothelial growth factor (VEGF)-B restores insulin sensitivity and glucose tolerance by inhibiting endothelial-to-tissue lipid transport, opening promising avenues for diabetes therapy.

Original languageEnglish
Pages (from-to)553-555
Number of pages3
JournalCell metabolism
Issue number5
StatePublished - Nov 7 2012


Dive into the research topics of 'Treating diabetes by blocking a vascular growth factor'. Together they form a unique fingerprint.

Cite this